Last updated: September 14, 2021
Sponsor: Heart Center Leipzig - University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Heart Failure
Chest Pain
Hyponatremia
Treatment
N/AClinical Study ID
NCT05055180
HFpEF-PHT 1.1
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
HFpEF Inclusion Criteria:
- Clinical signs of heart failure
- Preserved Left ventricular (LV) Ejection Fraction (EF >= 50%)
- Structural Heart Diseases on echocardiogram/ N terminal-pro-brain natriuretic peptide > 125ng/l
- Elevated LV end-diastolic pressure at rest (>15mmHg) or during exertion (>=25mmHg) No Heart Failure Inclusion Criteria:
- No signs of heart failure
- Preserved Left ventricular (LV) Ejection Fraction (EF >= 50%)
- Normal LV end-diastolic pressure at rest (=<15mmHg) and during exertion (<25mmHg)
Exclusion
Exclusion Criteria:
- Significant coronary artery stenosis at time of catheterization
- Acute coronary syndrome or cerebral insult within 1 month of examination
- more than moderate valvular diseases
- pregnancy
- contraindication to cardiac magnetic resonance imaging
Study Design
Total Participants: 45
Study Start date:
October 01, 2018
Estimated Completion Date:
December 30, 2021
Connect with a study center
Heart Center Leipzig at Leipzig University
Leipzig, Saxony 04289
GermanyActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.